Search for an Ozempic prescription in the EU and you will find page after page explaining how to qualify. Most of them skip the one fact that matters: in the European Union, Ozempic is a diabetes medicine. It is licensed for adults with type 2 diabetes, doctors prescribe it on that basis, and it is not licensed for weight loss.
None of that makes Ozempic less important. For the right person it lowers blood sugar, helps with weight and protects the heart. This guide explains who those people are, how a doctor decides, what treatment involves week to week, and what to do if your real question is about weight rather than diabetes.
In brief
- Licensed use in the EU: adults with type 2 diabetes whose blood sugar is not controlled well enough with diet and exercise, usually alongside metformin.
- Not licensed for: weight loss, type 1 diabetes, diabetic ketoacidosis, or anyone under 18.
- The weight-management alternative: Wegovy, the same molecule in a different product, licensed for obesity.
- How it is taken: one injection a week, with the dose raised in steps by your doctor.
- Who decides: the treating doctor, after reviewing your diagnosis, medical history and other medicines.
What Ozempic Is, and What It Isn't
Ozempic is the brand name for semaglutide, a GLP-1 receptor agonist made by Novo Nordisk. It copies a hormone your gut releases after a meal. Once a week, injected under the skin, it does three things at once: it prompts the pancreas to release insulin when blood sugar is high, it dampens glucagon (the hormone that pushes blood sugar up), and it slows the emptying of the stomach, so a meal reaches the blood more gradually and you feel full for longer.
That last effect is why so many people lose weight on it, and why the same molecule now appears in three products. This is where the confusion starts.
|
Product |
What it is |
Licensed in the EU for |
|
Ozempic |
Semaglutide, weekly injection, up to 2 mg |
Type 2 diabetes in adults |
|
Rybelsus |
Semaglutide, daily tablet |
Type 2 diabetes in adults |
|
Wegovy |
Semaglutide, weekly injection, up to 2.4 mg |
Weight management in adults with obesity, or with overweight and a weight-related condition, and in adolescents from 12 with obesity |
Ozempic is not insulin, it does not replace insulin, and it is not a treatment for type 1 diabetes.
Who Doctors Prescribe Ozempic To in the EU
The European licence, granted in 2018, is specific. Ozempic is for adults with type 2 diabetes that is not sufficiently controlled by diet and exercise, either added to metformin and other diabetes medicines, or on its own when metformin cannot be taken because of side effects or a contraindication.
In practice, a doctor will usually consider it when:
- type 2 diabetes has been confirmed with blood tests, typically HbA1c;
- HbA1c is still above target despite lifestyle changes and first-line treatment;
- there is a particular reason to choose a GLP-1 medicine, such as established heart disease, chronic kidney disease, or weight that is making the diabetes harder to control;
- nothing in the medical history argues against it.
Some people are ruled out from the start. Ozempic must not be used by anyone allergic to semaglutide, and it is not a treatment for type 1 diabetes or diabetic ketoacidosis. It is not recommended in pregnancy or while breastfeeding, and it should be stopped at least two months before a planned pregnancy. It has not been studied in children and adolescents, so it is not used under 18, and it is not recommended for people with severe stomach or bowel disease such as gastroparesis.
Others can take it but need extra care: anyone with a history of pancreatitis, people with diabetic retinopathy who also use insulin (a rapid improvement in blood sugar can temporarily worsen the eyes, so they need regular eye checks), people on insulin or a sulfonylurea (the doctor may lower those doses to avoid low blood sugar), and people with kidney problems, for whom the vomiting or diarrhoea of the first weeks can be dehydrating.
Why "Ozempic for Weight Loss" Is Not a Prescription You Can Ask For
People do lose weight on Ozempic. Appetite drops, portions shrink, and the trial data are real. But in the EU the weight-loss licence went to Wegovy, which was studied and dosed for obesity. Prescribing Ozempic for weight loss is off-label: a doctor may do so only within their country's professional rules, taking personal responsibility for the decision, and few will when a licensed alternative exists.
There is a second reason. From 2023 into 2025, Ozempic was in short supply across Europe, partly because of off-label demand, and some people with diabetes went without their medicine. The European Medicines Agency asked prescribers to reserve it for type 2 diabetes and warned about falsified Ozempic pens sold outside the regulated pharmacy chain, some of which put people in hospital.
So if weight is the concern, the right starting point is not a brand name. It is a conversation about medical weight management with a doctor, who will look at your BMI, your health history and your previous attempts, and at the medicines that are actually licensed for weight loss, including Wegovy and Mounjaro, alongside the eating and activity plan that makes them work.
What Happens at the Consultation
Whether it takes place in a clinic or by video, a proper Ozempic consultation follows the same path.
1. Where you are with your diabetes
The doctor confirms the diagnosis and looks at your recent HbA1c results, how long you have had diabetes, what you take now and how well it is working. If your numbers are close to target on metformin alone, Ozempic may not be the next step.
2. Your history and your other medicines
Pancreatitis, gallbladder disease, stomach or bowel problems, eye disease and kidney function all matter, as do any plans for pregnancy. Every other medicine matters too, because a slower stomach can change how quickly some tablets are absorbed.
3. The options, not just one of them
Type 2 diabetes has several treatment classes: metformin, SGLT2 inhibitors, DPP-4 inhibitors, GLP-1 medicines and insulin among them. A good consultation weighs where a GLP-1 medicine fits for you, including its benefits for the heart and kidneys, against the alternatives.
4. If Ozempic is the choice
You leave knowing how to inject, what the starting dose is for, what the first weeks usually feel like, what to do about side effects, and when your next check is. The prescription goes to a pharmacy, and the dose is increased later only on the doctor's say-so.
In many EU countries, you can have this consultation online, with a licensed doctor issuing an electronic prescription. Some countries require the first prescription to be issued in person and allow repeat prescriptions remotely; the doctor follows the rules of the country you are in.
How Ozempic Is Taken
Ozempic comes in a pre-filled pen and is injected under the skin of the abdomen, thigh, or upper arm once a week, on the same day each week, at any time of day, with or without food.
The dose is built up in steps. Treatment starts at 0.25 mg a week for four weeks; this starting dose lets your stomach adjust and does not control blood sugar on its own. It then moves to 0.5 mg. If blood sugar is still above target and the medicine is well tolerated, the doctor can raise it to 1 mg after at least four more weeks, and later to a maximum of 2 mg.
If you miss a dose and fewer than five days have passed, take it as soon as you remember. If more than five days have passed, skip it and take the next dose on your usual day. Keep unopened pens in the fridge; a pen in use can be kept at room temperature (below 30 °C) or in the fridge for up to six weeks, with the cap on and never frozen. If you travel, a small cool bag solves most problems.
The dose should never be changed, paused or stopped without medical advice.
Side Effects: What Is Normal and What Is Not
Digestive symptoms are the rule rather than the exception in the first weeks and after each dose increase. Nausea and diarrhoea are very common; vomiting, constipation, abdominal pain, bloating, indigestion, reflux, a smaller appetite and tiredness are common. Most people find that smaller meals, plenty of fluids and less fatty food take the edge off, and that the symptoms fade as the body adjusts. If they do not, tell your doctor: the dose can be held at a lower step for longer.
Low blood sugar is uncommon with Ozempic on its own but very common when it is combined with insulin or a sulfonylurea. Shakiness, sweating, sudden hunger, a racing heart and confusion are the signs to know.
A few side effects are rare but serious and need urgent, in-person care: severe and persistent abdominal pain, sometimes spreading to the back, with nausea or vomiting (possible pancreatitis); pain under the right ribs with fever or yellowing skin (gallbladder problems); swelling of the face, lips or throat or difficulty breathing (a severe allergic reaction); a sudden change in your vision; or vomiting so persistent that you cannot keep fluids down. In those situations, call 112 or go to an emergency department. Mobi Doctor must not be used in a medical emergency.
One more thing your doctor will want to know: any personal or family history of thyroid cancer. Semaglutide caused thyroid C-cell tumours in rodent studies. The EU product information records this as an animal finding; the US label goes further and carries a warning for people with a history of medullary thyroid carcinoma or MEN 2.
The patient leaflet in the box and the product information published by the European Medicines Agency are the complete references; a doctor or pharmacist can explain what applies to you.
Follow-up: Ozempic Is a Long-term Treatment
Ozempic is not a course that ends after a set number of weeks. Expect an HbA1c test about every three months at first, then every three to six months once you are stable; a check on weight and side effects at each review; kidney function tests where relevant; eye checks if you have diabetic retinopathy and use insulin; and a dose review before each step up. Repeat prescriptions need a doctor's review, so keep those appointments even when you feel well.
If you travel within the EU, carry the pens in their box with your prescription or a copy of it, keep them cool, and know that a doctor can review your treatment online if you run into trouble away from home.
Talking to a Doctor About Ozempic on Mobi Doctor
Mobi Doctor is an online platform run by Mobidoctor Ltd, Malta. Licensed doctors consult by video and questionnaire in 14 EU countries, daily from 7 am to 11 pm. If you have type 2 diabetes and questions about Ozempic, whether that is starting it, a dose change, side effects or a repeat prescription while you are travelling in the EU, you can book a video consultation and talk it through with a doctor.
The doctor reviews your diagnosis, history and current treatment and decides what is appropriate under the rules of the country you are in. Where a prescription is issued, it goes to a pharmacy you choose; Mobidoctor does not sell or dispense medicines.
